Visby Medical

San Jose, United States Founded: 2010 • Age: 16 yrs
Portable PCR diagnostics for infectious diseases are developed.
Request Access

About Visby Medical

Visby Medical is a company based in San Jose (United States) founded in 2010 by Adam De la Zerda.. Visby Medical has raised $386.33 million across 12 funding rounds from investors including Cedars Sinai, NIH and HHS. Visby Medical offers products and services including Sexual Health Test and Respiratory Health Test. Visby Medical operates in a competitive market with competitors including Inflammatix, MeMed, GenMark Diagnostics, Molbio Diagnostics and Sunbird Bio, among others.

  • Headquarter San Jose, United States
  • Founders Adam De la Zerda
  • Stage Unicorn
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Visby Medical, Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $386.33 M (USD)

    in 12 rounds

  • Latest Funding Round
    $55 M (USD), Series F

    Jun 18, 2025

  • Investors
    Cedars Sinai

    & 14 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Visby Medical

Visby Medical offers a comprehensive portfolio of products and services, including Sexual Health Test and Respiratory Health Test. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Rapid PCR test for detecting sexually transmitted infections in minutes.

Rapid PCR test for identifying respiratory illnesses quickly and accurately.

People of Visby Medical
Headcount 200-500
Employee Profiles 27
Employee Profiles
People
Jun Wang
Head Of Supply Chain
People
Brian Ciopyk
Engineering
People
Jennifer Albrecht
Research & Development
People
Shaunak Roy
Research & Development

Unlock access to complete

Funding Insights of Visby Medical

Visby Medical has successfully raised a total of $386.33M across 12 strategic funding rounds. The most recent funding activity was a Series F round of $55 million completed in June 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 12
  • Last Round Series F — $55.0M
  • First Round

    (04 Nov 2015)

  • Investors Count 15
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2025 Amount Series F - Visby Medical Valuation Catalio Capital Management
Jun, 2022 Amount Series E - Visby Medical Valuation Lightrock , John Doerr
Mar, 2022 Amount Series E - Visby Medical Valuation Hoopp , Sinai
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Visby Medical

Visby Medical has secured backing from 15 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Cedars Sinai, NIH and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Angel
Investor Description Founded Year Domain Location
Investments are directed toward growth-stage companies generating scalable impact.
Founded Year Domain Location
Tech startups are invested in by this venture capital firm.
Founded Year Domain Location
Venture capital firm investing in technology and healthcare sectors.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Visby Medical

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Visby Medical

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Visby Medical Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Visby Medical

Visby Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inflammatix, MeMed, GenMark Diagnostics, Molbio Diagnostics and Sunbird Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of diagnostic solutions for systemic infections
domain founded_year HQ Location
Provider of machine learning based diagnostic solutions for infectious diseases
domain founded_year HQ Location
Instruments and test panels for multiplexed molecular diagnostics are provided.
domain founded_year HQ Location
Point-of-care molecular platforms for infectious disease detection are developed.
domain founded_year HQ Location
Diagnostic technologies for infectious, cancer, and neurological diseases are developed.
domain founded_year HQ Location
Miniaturized MRI platforms for clinical diagnostics are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Visby Medical

Frequently Asked Questions about Visby Medical

When was Visby Medical founded?

Visby Medical was founded in 2010 and raised its 1st funding round 5 years after it was founded.

Where is Visby Medical located?

Visby Medical is headquartered in San Jose, United States. It is registered at San Jose, California, United States.

Who is the current CEO of Visby Medical?

Adam De la Zerda is the current CEO of Visby Medical. They have also founded this company.

Is Visby Medical a funded company?

Visby Medical is a funded company, having raised a total of $386.33M across 12 funding rounds to date. The company's 1st funding round was a Series E of $100M, raised on Nov 04, 2015.

What does Visby Medical do?

Visby Medical was founded in 2010 and is headquartered in San Jose, United States. Diagnostic products targeted at infectious diseases are developed within the medical technology sector. Operations center on creating portable, instrument-free PCR tests that can be held in the palm and used to identify serious respiratory and sexually transmitted infections through rapid testing methods.

Who are the top competitors of Visby Medical?

Visby Medical's top competitors include Inflammatix, MeMed and GenMark Diagnostics.

What products or services does Visby Medical offer?

Visby Medical offers Sexual Health Test and Respiratory Health Test.

Who are Visby Medical's investors?

Visby Medical has 15 investors. Key investors include Cedars Sinai, NIH, HHS, Lightrock, and John Doerr.

What is Visby Medical's valuation?

The valuation of Visby Medical is $1B as of Jun 2022.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available